Experts fear ‘unethical’ vaccine trial in Africa is ‘prototype’ for US studies under RFK Jr
AI Summary
Experts are concerned that a suspended hepatitis B vaccine trial in Guinea-Bissau, conducted by Danish researchers, may be a model for future studies under Robert F. Kennedy Jr., raising ethical concerns about US-funded global research. The trial, which only vaccinated half of newborns despite a high prevalence of hepatitis B, is under scrutiny by Stand Up for Science, who sent an investigator to Guinea-Bissau to investigate the study. The organization presented their findings to Congress, highlighting potential ethical issues within the Bandim Health Project and its influence on public health in Guinea-Bissau. Concerns stem from the researchers' past practices of releasing partial or no results from studies and their ties to the current US administration, specifically Kennedy, who has cited one of the researchers as influential. Critics fear this approach could lead to unethical and potentially deadly research practices on a larger scale.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories
Find Similar Articles
AI-PoweredDiscover articles with similar content using semantic similarity analysis.